Now showing items 21-27 of 27

    • Pulmonary renal syndrome in an adult patient with Henoch-Shönlein purpura 

      Eleftheriadis, Th; Liakopoulos, V.; Boulbou, M.; Karasavvidou, F.; Atmatzidis, E.; Dovas, S.; Antoniadi, G.; Stefanidis, I. (2006)
      Henoch-Schönlein purpura (HSP) is a small vessel vasculitis characterized by purpuric skin rash, haematuria, abdominal pain, gastrointestinal bleeding and arthritis. Nephritis is more frequent and severe in adults than in ...
    • A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis 

      Zachou K., Gatselis N.K., Arvaniti P., Gabeta S., Rigopoulou E.I., Koukoulis G.K., Dalekos G.N. (2016)
      Background Front-line therapy with mycophenolate mofetil (MMF) in autoimmune hepatitis (AIH) has shown high on-treatment remission rates. Aim To study prospectively in a real-world fashion the long-term outcome of a large ...
    • Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece 

      Rigopoulos D., Patsatsi A., Antoniou C., Sotiriadis D., Roussaki-Schulze A., Boubouchairopoulou N., Skiadas I., Tsekouras V., Daly A.C.H. (2022)
      Etanercept is approved for continuous or intermittent use and flexible dosing in plaque psoriasis (PsO). The objectives of this study were to investigate real-world treatment patterns with etanercept in Greek adults with ...
    • Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study 

      Rouzé A., Martin-Loeches I., Povoa P., Makris D., Artigas A., Bouchereau M., Lambiotte F., Metzelard M., Cuchet P., Boulle Geronimi C., Labruyere M., Tamion F., Nyunga M., Luyt C.-E., Labreuche J., Pouly O., Bardin J., Saade A., Asfar P., Baudel J.-L., Beurton A., Garot D., Ioannidou I., Kreitmann L., Llitjos J.-F., Magira E., Mégarbane B., Meguerditchian D., Moglia E., Mekontso-Dessap A., Reignier J., Turpin M., Pierre A., Plantefeve G., Vinsonneau C., Floch P.-E., Weiss N., Ceccato A., Torres A., Duhamel A., Nseir S., Favory R., Preau S., Jourdain M., Poissy J., Bouras C., Saint Leger P., Fodil H., Aptel F., Van Der Linden T., Thille A.W., Azoulay E., Pène F., Razazi K., Bagate F., Contou D., Voiriot G., Thevenin D., Guidet B., Le Guennec L., Kouatchet A., Ehrmann S., Brunin G., Morawiec E., Boyer A., Argaud L., Voicu S., Nieszkowska A., Kowalski B., Goma G., Diaz E., Morales L., Tsolaki V., Gtavriilidis G., Mentzelopoulos S.D., Nora D., Boyd S., Coelho L., Maizel J., Du Cheyron D., Imouloudene M., Quenot J.-P., Guilbert A., Cilloniz C., on behalf of the coVAPid study Group (2021)
      Purpose: Although patients with SARS-CoV-2 infection have several risk factors for ventilator-associated lower respiratory tract infections (VA-LRTI), the reported incidence of hospital-acquired infections is low. We aimed ...
    • Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial 

      Woodhouse L.J., Scutt P., Hamdy S., Smithard D.G., Cohen D.L., Roffe C., Bereczki D., Berge E., Bladin C.F., Caso V., Christensen H.K., Collins R., Czlonkowska A., de Silva A., Etribi A., Laska A.-C., Ntaios G., Ozturk S., Phillips S.J., Prasad K., Szatmari S., Sprigg N., Bath P.M. (2018)
      Post-stroke dysphagia is common, associated with poor outcome and often requires non-oral feeding/fluids. The relationship between route of feeding and outcome, as well as treatment with glyceryl trinitrate (GTN), was ...
    • Surveillance and control of communicable diseases related to passenger ships in Europe 

      Hadjichristodoulou, C.; Mouchtouri, V. A.; Martinez, C. V.; Nichols, G.; Riemer, T.; Rabinina, J.; Swan, C.; Pirnat, N.; Sokolova, O.; Kostara, E.; Rachiotis, G.; Meilicke, R.; Schlaich, C.; Bartlett, C. L.; Kremastinou, J.; Partnership, T. S. (2011)
      This study was conducted within the European SHIPSAN (ship sanitation) project and aims at exploring the legislative framework and current practices related to surveillance of communicable diseases and response aboard ...
    • Upadacitinib tartrate in rheumatoid arthritis 

      Stamatis P., Bogdanos D.P., Sakkas L.I. (2020)
      does not achieve low disease activity or remission despite the use of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) and/or biological DMARDs (bDMARDs). The Janus kinase (JAK) inhibitors are the ...